Loading insider details...
Latest Form 4 (Jun 17, 2026): Purchase of 250,000 NRSN shares, $200.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | NeuroSense Therapeutics Ltd. (NRSN) | Purchase | 250,000 | $200.0K |
| Apr 1, 2026 | NeuroSense Therapeutics Ltd. (NRSN) | Grant/Award | 200,000 | n/a |
| Mar 11, 2021 | Wize Pharma, Inc. (WIZP) | Purchase | 833,333 | $100.0K |